High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma

International Journal of Cancer

Volumn 69, Issue 6, 1996, Pages 448-451

  Chenard, Marie Pierre ^a   O'Siorain, Liam ^b   Shering, Stephen ^c   Rouyer, Nicolas ^a   Lutz, Yves ^d   Wolf, Catherine ^a   Basset, Paul ^d   Bellocq, Jean Pierre ^a   Duffy, Michael Joseph ^e  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Our Lady's Hospice Ltd Dublin   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; STROMELYSIN 3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DRUG THERAPY, COMBINATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 3; PROGNOSIS; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0030467609     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.0.CO;2-4     Document Type: Article

References (23)

1. AZNAVOORIAN, S., MURPHY, A.C., STETLER-STEVENSON, W.G. and LIOTTA, L., Molecular aspects of tumor-cell invasion and metastasis. Cancer, 71, 1368-1383 (1993).
2. BASSET, P., BELLOCO, J-P., WOLF, C., STOLL, I., HUTIN, P., LIMACHER, J.M., PODHAJCER, O.L., CHENARD, M.P., Rio, M.C. and CHAMBON, P., A novel metalloprotease gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348, 699-704 (1990).
3. BASSET, P., WOLF, C. and CHAMBON, P., Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res. Treat., 24, 185-193 (1993).
4. BIRKEDAL-HANSEN, H., Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol., 7, 728-735 (1995).
5. BROWN, P.D. and GIAVAZZI, R., Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann. Oncol., 6, 967-974 (1995).
6. DAIDONE, M.G., SILVESTRINI, R., D'ERRICO, A., D'FRONZO, G., BENINI, A.M., GARBISA, S., LIOTTA, L. and GRIGIONI, W., Laminin receptors, collagenase IV and prognosis in node-negative breast cancer. Int. J. Cancer, 48, 529-532 (1991).
7. DUFFY, M.J., The role of proteolytic enzymes in cancer invasion and metastasis. Clin. exp. Metast., 10, 145-155 (1992).
8. DUFFY, M.J., Proteases as prognostic markers in cancer. Clin. Cancer Res., 2, 613-618 (1996).
9. ENGEL, G., HESELMEYER, K., AUER, G., BACKDAHL, M., ERIKSSON, E. and LINDER, S., Correlation between stromelysin-3 mRNA levels and outcome of human breast cancer. Int. J. Cancer, 58, 830-835 (1994).
10. HÄHNEL, R., Prospective study of stromelysin-3 expression in breast-cancer biopsies and disease-free survival. Int. J. Oncol, 7, 1315-1318 (1995).
11. HÄHNEL, E., HARVEY, J.M., JOYCE, R., ROBBINS, P., STERRETT, G. and HÄHNEL, R., Stromelysin-3 expression in breast-cancer biopsies: clinicopathological correlations. Int. J. Cancer, 55, 771-774 (1993).
12. HODGSON, J., Remodeling MMPIs. Biotechnology, 13, 554-558 (1995).
13. LE DOUSSAL, V., TUBIANA-HULIN, M., FRIEDMAN, S., HACENE, K., SPYRATOS, F.and BRUNET, M., Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). Cancer, 64, 1914-1921 (1989).
14. MACDOUGALL, J.R. and MATRISIAN, L.M., Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast. Rev., 14, 351-362 (1995).
15. NOËL, A.C., LEFEBVRE, O., MAQUOI, E., VANHOORDE, L., CHENARD, M.P., MAREEL, M., FOIDART, J.M., BASSET, P. and RIO, M.C., Stromelysin-3 expression promotes tumor take in nude mice. J. clin. Invest., 97, 1924-1930 (1996).
16. NOËL, A., SANTAVICCA, M., STOLL, I., L'HOIR, C., STAUB, A., MURPHY, G., Rio, M.C. and BASSET, P., Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities. J. biol. Chem., 270, 22866-22872 (1995).
17. PEI, D., MAJMUDAR, G. and WEISS, S.J., Hydrolytic inactivation of a breast-carcinoma-cell-derived serpin by human stromelysin-3. J. biol. Chem., 269, 25849-25855 (1994).
18. PEI, D. and WEISS, S.J., Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (Lond.), 375, 244-247 (1995).
19. ROUYER, N., WOLF, C., CHENARD, M.P., Rio, M.C., CHAMBON, P., BELLOCQ, J.P. and BASSET, P., Stromelysin-3-gene expression in human cancer: an overview. Invasion Metastasis, 14, 269-275 (1994).
20. SANTAVICCA, M., NOËL, A., ANGLIKER, H., STOLL, I., SEGAIN, J.P., ANGLARD, P., CHRETIEN, M., SEIDAH, N. and BASSET, P., Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochem. J., 315, 953-958 (1996).
21. SANTAVICCA, M., NOËL, A., CHENARD, M.P., LUTZ, Y., STOLL, I., SEGAIN, J.P., ROUYER, N., Rio, M.C., WOLF, C., BELLOCQ, J.P. and BASSET, P., Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry. Int. J. Cancer, 64, 336-341 (1995).
22. VISSCHER, D.W., HOYHTYA, M., OTTOSEN, S.K., LIANG, C.M., SARKAR, F.H. and CRISSMAN, J.D. and FRIDMAN, R., Enhanced expression of tissue inhibition of metalloproteinase (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59, 339-344 (1994).
23. WOLF, C., ROUYER, N., LUTZ, Y., ADIDA, C., LORIOT, M., BELLOCQ, J.P., CHAMBON, P. and BASSET, P., Stromelysin 3 belongs to a sub-group of proteinases expressed in breast-carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc. nat. Acad. Sci. (Wash.), 90, 1843-1847 (1993).